Randomised clinical trial: a placebo‐controlled study of intravenous golimumab induction therapy for ulcerative colitisP. Rutgeerts, Jewel Johanns, Omoniyi J. Adedokun et al.|Alimentary Pharmacology & Therapeutics|2015Cited by 86
DOP076 A phase 2B, multicenter, randomized, placebo-controlled dose-ranging trial of peficitinab, an oral JAK inhibitor, in patients with moderately to severely active ulcerative colitisBruce E. Sands, Colleen Marano, W. Sandborn et al.|Journal of Crohn s and Colitis|2017Cited by 1
Predictive value of patient-reported outcomes to mucosal healing in patients with moderately to severely active ulcerative colitisJ F Colombel, William J. Sandborn, Chenglong Han et al.|Value in Health|2014Cited by 0